FAT1 and anaplastic large cell lymphoma: These markers include FAT1 mutations, CD28 mutations in AITL, CDKN2A deletion in PTCL‐NOS, GATA‐3 expression, and TP63 structural abnormalities in ALK–ALCL (Table 5).24, 25, 26, 27, 28, 29, 30